Literature DB >> 1877243

Resolution of bowel obstruction due to newly diagnosed inoperable advanced ovarian cancer with medical therapy.

T P Drakes1.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1877243      PMCID: PMC1002927     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  8 in total

1.  Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival.

Authors:  D L Clarke-Pearson; E R DeLong; N Chin; R Rice; W T Creasman
Journal:  Arch Surg       Date:  1988-01

2.  Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer.

Authors:  J C Tunca
Journal:  Gynecol Oncol       Date:  1981-10       Impact factor: 5.482

3.  The management of ovarian-cancer-caused bowel obstruction.

Authors:  J C Tunca; D A Buchler; E A Mack; F F Ruzicka; J J Crowley; W F Carr
Journal:  Gynecol Oncol       Date:  1981-10       Impact factor: 5.482

4.  The role of intestinal intubation in obstruction of the small intestine due to carcinoma of the ovary.

Authors:  H B Krebs; D R Goplerud
Journal:  Surg Gynecol Obstet       Date:  1984-05

5.  Surgical management of bowel obstruction in advanced ovarian carcinoma.

Authors:  H B Krebs; D R Goplerud
Journal:  Obstet Gynecol       Date:  1983-03       Impact factor: 7.661

6.  Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer.

Authors:  P M Dvoretsky; K A Richards; C Angel; L Rabinowitz; J B Beecham; T A Bonfiglio
Journal:  Hum Pathol       Date:  1988-11       Impact factor: 3.466

7.  Malignant intestinal obstruction.

Authors:  R T Osteen; S Guyton; G Steele; R E Wilson
Journal:  Surgery       Date:  1980-06       Impact factor: 3.982

8.  Intestinal obstruction in cancer patients. An assessment of risk factors and outcome.

Authors:  H L Gallick; D W Weaver; R J Sachs; D L Bouwman
Journal:  Am Surg       Date:  1986-08       Impact factor: 0.688

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.